Navigation Links
Dr. Kristen Wright of RSC New England Discusses Secondary Infertility in “Why Can’t I Get Pregnant Again?”
Date:8/14/2014

Bedford, NH (PRWEB) August 14, 2014

Many women experience loneliness, shame, stress and sadness as they try over and over again to become pregnant when they are older, even after they have a child. They are dealing with secondary infertility. This is the focus of an article in the July 2014 issue of Parenting New Hampshire.

Secondary infertility is defined by the National Fertility Association as the inability to become pregnant or carry a pregnancy to term, after the birth of one or more biological children without the help of assisted reproductive technologies (ART), such as in-vitro fertilization (IVF) or fertility medication.

According to Dr. Kristen Wright, a two time winner of New Hampshire’s Top Doctors Award, almost half of the 15% of New Hampshire women who suffer from infertility actually have secondary infertility. Age is the biggest issue when it comes to getting pregnant again. "The chance of getting pregnant after 35 decreases substantially, and one or two years can make a big difference,” Dr. Wright comments. Conception can be harder due to pelvic scarring, ectopic pregnancy, fibroids and even polyps. And, there is also unexplained secondary infertility in which a cause cannot be identified.

A fertility consultation is recommended sooner rather than later because time is the major factor affecting pregnancy after 35. As part of a consultation at RSC New England, testing and counseling are conducted to determine what is going on, especially if a woman has experienced a tough pregnancy in the past. Working closely with the patient, a treatment plan is created, which may include fertility medication, IUI, IVF, donor eggs, as well as surrogacy and IVF. Egg freezing may be another option to preserve more youthful eggs before they are no longer viable.

Fertility treatments are much more advanced than a generation ago. Dr. Wright notes, “We have so many more ways we can help couples,” including selecting the strongest sperm for insemination and identifying the most viable embryos for implantation.

For more information or to schedule a consultation, please call 800.858.4832.

About Reproductive Science Center of New England

Since 1988, Reproductive Science Center of New England is one of the largest and most experienced fertility treatment centers in the United States, providing comprehensive infertility diagnosis, advanced infertility treatment options, fertility preservation, and exceptional patient care. RSC New England has 11 locations in Massachusetts, New Hampshire and Rhode Island and is a partner member of IntegraMed Fertility, the most expansive network of infertility treatment centers and fertility specialist physicians in the nation.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12094288.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. American Federation for Aging Research Announces Recipients of Irving S. Wright and Vincent Cristofalo Scientific Awards
2. Samuel Pang, MD and Isaac Glatstein, MD of the Reproductive Science Center of New England, Rated Top Docs in Infertility Diagnosis and Treatment by Boston Magazine
3. RSC New England Clinicians to Present at RESOLVE New England’s 20th Annual Conference on November 2nd, 2013
4. Population Genetics Assigns Asymmetric Adaptor Library Construction Patent To New England Biolabs
5. New England Biolabs supports iGEM synthetic biology competition
6. New England Biolabs Releases the NEBNext Microbiome DNA Enrichment Kit
7. Sigma Life Science and the Culture Collections of Public Health England Collaborate to Distribute Cells and Cellular Extracts
8. New England Biolabs opens seventh subsidiary in Singapore
9. Quadrant Engineering Plastic Products Appoints a New England Territorial Manager and Production Supervisor
10. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
11. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... MA (PRWEB) , ... February 24, 2017 , ... ... replacement (TDR) procedures can be safely completed in an ambulatory surgery center (ASC) ... fusion (ACDF) procedures and previous two-year TDR studies. , Jake Lubinski, president ...
(Date:2/24/2017)... 24, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... participate in its previously announced rights offering of ... of common stock and Series C Convertible Preferred ... warrants. As previously announced, the ...
(Date:2/24/2017)... , Feb. 24, 2017  Driven by consumers, ... are now the fastest growing categories, finds the ... Actives in Personal Care: Multi-regional Market Analysis and ... management consulting firm Kline. "Biotechnology actives ... make them more effective for skin and hair ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" ... in China, today announced its financial results for the fourth ... Quarter 2016 Financial Highlights Total sales ... RMB terms, or increased by 13.6% in USD terms to ... 2015. Gross profit increased by 13.3% to ...
Breaking Biology Technology:
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
Breaking Biology News(10 mins):